(Q35901358)

11 August 2017

1 reference

title

Cross-national comparison of technology assessment processes (English)

1 reference

11 August 2017

3

Peter J Neumann

1 reference

11 August 2017

Anna García-Altés

1

1 reference

11 August 2017

Silvia Ondategui-Parra

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2004

1 reference

International Journal of Technology Assessment in Health Care

11 August 2017

published in

1 reference

11 August 2017

volume

20

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

300-310

1 reference

Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

Technology assessment and the sociopolitics of health technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

Assessing the impact of health technology assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

Medical innovation and the critical role of health technology assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

Priority setting for health technology assessment. Theoretical considerations and practical approaches. Priority setting Subgroup of the EUR-ASSESS Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

The influence of technology assessments by advisory bodies on health policy and practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

The influence of health technology assessment on the diffusion of MRI in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

A history of ISTAHC. A personal perspective on its first 10 years. International Society of Technology Assessment in Health Care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

The role of economic appraisal in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

EUR-ASSESS Project Subgroup Report on Dissemination and Impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

The use of societal criteria in priority setting for health technology assessment in The Netherlands. Initial experiences and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

EUR-ASSESS Project Subgroup Report on Coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

Identification and priority setting for health technology assessment in The Netherlands: actors and activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

Liquid-based cytology for cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

Systems for routine information sharing in HTA. Working group 2 report

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

Report from the Australian Institute of Health and Welfare, Canberra, Health Technology Division. Perceptions of Australian Health Technology Assessments: report of a survey

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY ASSESSMENTS

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: a rapid and systematic review.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

Improvements in medicare coverage of new technology

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

Pharmaceutical regulation: the early experience of the NHS National Institute for Clinical Excellence (NICE) appraisal process--where are we headed?

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

Health technology assessment in the United States. Past, present, and future

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

The National Center for Health Care Technology

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

The status of health technology assessment worldwide. Results of an international survey

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

Setting priorities for the adoption of health technologies on a national level -- the Israeli experience

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0266462304001126

7 January 2021

10.1017/S0266462304001126

Identifiers

DOI

1 reference

11 August 2017

1 reference